Study of Anlotinib as the Maintenance Therapy for Extensive-stage Small Cell Lung Cancer
Clinical trial NCT03781869 · UNKNOWN
Trial details
- NCT number
- NCT03781869
- Sponsor
- Third Military Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-01
- Primary completion
- 2020-12-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.